Regenerative Medical Technology Group Inc.
RMTG
$0.03
$0.0027.14%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.65M | 4.11M | 3.21M | 2.87M | 2.44M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.65M | 4.11M | 3.21M | 2.87M | 2.44M |
| Cost of Revenue | 1.46M | 1.28M | 934.40K | 891.70K | 732.80K |
| Gross Profit | 3.20M | 2.82M | 2.28M | 1.98M | 1.71M |
| SG&A Expenses | 2.65M | 2.47M | 2.31M | 2.10M | 2.09M |
| Depreciation & Amortization | 195.80K | 220.60K | 345.30K | 355.20K | 330.10K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.30M | 3.97M | 3.59M | 3.35M | 3.16M |
| Operating Income | 350.30K | 133.50K | -382.40K | -478.30K | -716.10K |
| Income Before Tax | -4.36M | -5.56M | -5.18M | -10.15M | -10.10M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.36 | -5.56 | -5.18 | -10.15 | -10.10 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.36M | -5.56M | -5.18M | -10.15M | -10.10M |
| EBIT | 350.30K | 133.50K | -382.40K | -478.30K | -716.10K |
| EBITDA | 629.00K | 436.90K | -37.10K | -123.10K | -386.00K |
| EPS Basic | -0.35 | -0.44 | -0.41 | -0.81 | -0.81 |
| Normalized Basic EPS | -0.22 | -0.28 | -0.33 | -0.38 | -0.38 |
| EPS Diluted | -0.35 | -0.44 | -0.41 | -0.81 | -0.81 |
| Normalized Diluted EPS | -0.22 | -0.28 | -0.33 | -0.38 | -0.38 |
| Average Basic Shares Outstanding | 50.11M | 50.07M | 49.98M | 49.89M | 49.84M |
| Average Diluted Shares Outstanding | 50.11M | 50.07M | 49.98M | 49.89M | 49.84M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |